Equasens Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
834
- Stock Symbol
-
EQS
- Investments
-
28
- Share Price
-
$29.46
- (As of Wednesday Closing)
Equasens General Information
Description
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
Contact Information
Website
www.equasens.comCorporate Office
- 5 Allée de Saint-Cloud
- 54600 Villers-les-Nancy
- France
Corporate Office
- 5 Allée de Saint-Cloud
- 54600 Villers-les-Nancy
- France
Equasens Stock Performance
As of 18-Nov-2026, Equasens’s stock price is $29.46. Its current market cap is $443M with 15M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $29.46 | $30.30 | $28.57 - $53.39 | $443M | 15M | 25.3K | $2.92 |
Equasens Financials Summary
As of 31-Dec-2025, Equasens has a trailing 12-month revenue of $267M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 815,274 | 815,274 | 715,784 | 1,018,332 |
| Revenue | 266,796 | 266,796 | 234,547 | 237,827 |
| EBITDA | 73,359 | 73,359 | 62,758 | 72,965 |
| Net Income | 44,364 | 44,364 | 39,206 | 50,908 |
| Total Assets | 515,641 | 515,641 | 414,160 | 435,577 |
| Total Debt | 71,518 | 71,518 | 58,093 | 72,980 |
Equasens Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Equasens Patents
Equasens Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-2813476-A1 | External sales and consulting support network for products and articles | Active | 24-Aug-2000 | ||
| FR-2813476-B1 | External sales and consulting support network for products and articles | Inactive | 24-Aug-2000 | ||
| EP-1182601-A1 | External shopping aid and recommendation network for products and articles | Inactive | 24-Aug-2000 | G06Q30/06 |
Equasens Signals
Equasens Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Equasens Investments & Acquisitions (28)
Equasens’s most recent deal was a Merger/Acquisition with Erevo (Education and Training Services (B2B)). The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Erevo (Education and Training Services (B2B)) | 01-Dec-2025 | Merger/Acquisition | Education and Training Services (B2B) | ||
| Calimed Santé | 27-Dec-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Digipharmacie | 02-Jan-2024 | Merger/Acquisition | Other Financial Services | ||
| Apotheken Datenverarbeitung | 23-Nov-2023 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Atoopharm | 06-Apr-2023 | Merger/Acquisition | Educational and Training Services (B2C) |
Equasens ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
18.71 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Health Care IT Services
Subindustry
of 50
Rank
Percentile
Equasens Exits (3)
Equasens’s most recent exit was on 01-Jan-2015 from Int Écum. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Int Écum | 01-Jan-2015 | Completed |
|
||
| DOmedic | 01-May-2011 | Completed |
|
||
| Int Écum | 01-Dec-2010 | Secondary Transaction - Private | Completed |
Equasens Affiliates
Subsidiaries (17)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Speech2Sense | Roubaix, France | 2019 | |
| Digipharmacie | Paris, France | 2019 | |
| Erevo (Education and Training Services (B2B)) | Marseille, France | 2018 | |
| Nanceo | Clichy, France | 2015 | |
| Kapelse | Villers-Les-Nancy, France | 2013 |
Equasens FAQs
-
When was Equasens founded?
Equasens was founded in 1996.
-
Where is Equasens headquartered?
Equasens is headquartered in Villers-les-Nancy, France.
-
What is the size of Equasens?
Equasens has 834 total employees.
-
What industry is Equasens in?
Equasens’s primary industry is Business/Productivity Software.
-
Is Equasens a private or public company?
Equasens is a Public company.
-
What is Equasens’s stock symbol?
The ticker symbol for Equasens is EQS.
-
What is the current stock price of Equasens?
As of 18-Nov-2026 the stock price of Equasens is $29.46.
-
What is the current market cap of Equasens?
The current market capitalization of Equasens is $443M.
-
What is Equasens’s current revenue?
The trailing twelve month revenue for Equasens is $267M.
-
What is Equasens’s annual earnings per share (EPS)?
Equasens’s EPS for 12 months was $2.92.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process